Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilmar Correa

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Biochimica Et Biophysica Acta|January 24, 2016
Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsisKlaus Brandenburg, Lena Heinbockel, Wilmar Correa, et al.
Microbial Pathogenesis|May 22, 2019
Antimicrobial peptides Pep19-2.5 and Pep19-4LF inhibit Streptococcus mutans growth and biofilm formationHanen Jannadi, Wilmar Correa, Ze Zhang, et al.
International Journal of Molecular Sciences|December 21, 2017
Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) PhenomenonWilmar Correa, Klaus Brandenburg, Ulrich Zähringer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2018
Peptide drug stability: The anti-inflammatory drugs Pep19-2.5 and Pep19-4LF in cream formulationNicole Kuhlmann, Lena Heinbockel, Wilmar Correa, et al.
Journal of Structural Biology|February 2, 2016
Supramolecular structure of enterobacterial wild-type lipopolysaccharides (LPS), fractions thereof, and their neutralization by Pep19-2.5Klaus Brandenburg, Lena Heinbockel, Wilmar Correa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 28, 2020
Encapsulation and release of As pidasept peptides in polysaccharide formulation for oral applicationNicole Kuhlmann, Christian Nehls, Lena Heinbockel, et al.
Expert Review of Anti-Infective Therapy|November 19, 2020
An update on endotoxin neutralization strategies in Gram-negative bacterial infectionsKlaus Brandenburg, Andra B Schromm, Günther Weindl, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2024
Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assayAndra B Schromm, Wilmar Correa, Nicolas Gisch, et al.
Biochimica Et Biophysica Acta|July 15, 2014
Galleria mellonella native and analogue peptides Gm1 and ΔGm1. I) biophysical characterization of the interaction mechanisms with bacterial model membranesWilmar Correa, Marcela Manrique-Moreno, Edwin Patiño, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 5, 2019
LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responsesAnja Pfalzgraff, Wilmar Correa, Lena Heinbockel, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Biochimica Et Biophysica Acta|January 24, 2016
Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsisKlaus Brandenburg, Lena Heinbockel, Wilmar Correa, et al.
Microbial Pathogenesis|May 22, 2019
Antimicrobial peptides Pep19-2.5 and Pep19-4LF inhibit Streptococcus mutans growth and biofilm formationHanen Jannadi, Wilmar Correa, Ze Zhang, et al.
International Journal of Molecular Sciences|December 21, 2017
Biophysical Analysis of Lipopolysaccharide Formulations for an Understanding of the Low Endotoxin Recovery (LER) PhenomenonWilmar Correa, Klaus Brandenburg, Ulrich Zähringer, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 17, 2018
Peptide drug stability: The anti-inflammatory drugs Pep19-2.5 and Pep19-4LF in cream formulationNicole Kuhlmann, Lena Heinbockel, Wilmar Correa, et al.
Journal of Structural Biology|February 2, 2016
Supramolecular structure of enterobacterial wild-type lipopolysaccharides (LPS), fractions thereof, and their neutralization by Pep19-2.5Klaus Brandenburg, Lena Heinbockel, Wilmar Correa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 28, 2020
Encapsulation and release of As pidasept peptides in polysaccharide formulation for oral applicationNicole Kuhlmann, Christian Nehls, Lena Heinbockel, et al.
Expert Review of Anti-Infective Therapy|November 19, 2020
An update on endotoxin neutralization strategies in Gram-negative bacterial infectionsKlaus Brandenburg, Andra B Schromm, Günther Weindl, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 24, 2024
Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assayAndra B Schromm, Wilmar Correa, Nicolas Gisch, et al.
Biochimica Et Biophysica Acta|July 15, 2014
Galleria mellonella native and analogue peptides Gm1 and ΔGm1. I) biophysical characterization of the interaction mechanisms with bacterial model membranesWilmar Correa, Marcela Manrique-Moreno, Edwin Patiño, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 5, 2019
LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responsesAnja Pfalzgraff, Wilmar Correa, Lena Heinbockel, et al.
Pageof 3